Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?

Por Hilkens, C M U, Isaacs, J D
Publicado em 2013

Bronchial epithelial cells cultured from clinically stable lung allograft patients promote the development of macrophages from monocytes rather than dendritic cells

Por Ward, C, Eger, K, Diboll, J, Jones, D, Haniffa, M A, Brodlie, M, Fisher, A, Lordan, J L, Corris, P A, Hilkens, C M U
Publicado em 2009

Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis

Por Reynolds, G, Gibbon, J R, Pratt, A G, Wood, M J, Coady, D, Raftery, G, Lorenzi, A R, Gray, A, Filer, A, Buckley, C D, Haniffa, M A, Isaacs, J D, Hilkens, C M U
Publicado no Ann Rheum Dis (2016)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis

Por Bell, G M, Anderson, A E, Diboll, J, Reece, R, Eltherington, O, Harry, R A, Fouweather, T, MacDonald, C, Chadwick, T, McColl, E, Dunn, J, Dickinson, A M, Hilkens, C M U, Isaacs, John D
Publicado no Ann Rheum Dis (2017)

Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4(+) T cells partly via transforming growth factor‐β1

Por Anderson, A. E., Swan, D. J., Wong, O. Y., Buck, M., Eltherington, O., Harry, R. A., Patterson, A. M., Pratt, A. G., Reynolds, G., Doran, J.‐P., Kirby, J. A., Isaacs, J. D., Hilkens, C. M. U.
Publicado no Clin Exp Immunol (2016)